PDS Financial Statements From 2010 to 2025
| EU6 Stock | EUR 1.41 0.02 1.44% |
Check PDS Biotechnology financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among PDS Biotechnology's main balance sheet or income statement drivers, such as , as well as many indicators such as . PDS financial statements analysis is a perfect complement when working with PDS Biotechnology Valuation or Volatility modules.
PDS |
PDS Biotechnology Corp Company Shares Outstanding Analysis
PDS Biotechnology's Outstanding Shares are shares of common stock of a public company that were purchased by investors after they were authorized and issued by the company to the public. Outstanding Shares are typically reported on fully diluted basis, including exotic instruments such as options, or convertibles bonds.
Current PDS Biotechnology Shares Outstanding | 28.89 M |
Most of PDS Biotechnology's fundamental indicators, such as Shares Outstanding, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, PDS Biotechnology Corp is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Outstanding shares that are stated on company Balance Sheet are used when calculating many important valuation and performance indicators including Return on Equity, Market Cap, EPS and many others.
| Competition |
Based on the latest financial disclosure, PDS Biotechnology Corp has 28.89 M of shares currently outstending. This is 84.0% lower than that of the Healthcare sector and 72.97% lower than that of the Biotechnology industry. The shares outstanding for all Germany stocks is 94.95% higher than that of the company.
PDS Biotechnology Corp Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining PDS Biotechnology's current stock value. Our valuation model uses many indicators to compare PDS Biotechnology value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across PDS Biotechnology competition to find correlations between indicators driving PDS Biotechnology's intrinsic value. More Info.PDS Biotechnology Corp is rated below average in return on equity category among its peers. It also is rated below average in return on asset category among its peers . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the PDS Biotechnology's earnings, one of the primary drivers of an investment's value.About PDS Biotechnology Financial Statements
PDS Biotechnology stakeholders use historical fundamental indicators, such as PDS Biotechnology's revenue or net income, to determine how well the company is positioned to perform in the future. Although PDS Biotechnology investors may analyze each financial statement separately, they are all interrelated. For example, changes in PDS Biotechnology's assets and liabilities are reflected in the revenues and expenses on PDS Biotechnology's income statement, which ultimately affect the company's gains or losses. Understanding these patterns can help in making the right long-term investment decisions in PDS Biotechnology Corp. Please read more on our technical analysis and fundamental analysis pages.
PDS Biotechnology Corporation, a clinical-stage biopharmaceutical company, focuses on developing multifunctional cancer immunotherapies. PDS Biotechnology Corporation was founded in 2005 and is based in Florham Park, New Jersey. PDS BIOTECHNOLOGY operates under Biotechnology classification in Germany and is traded on Frankfurt Stock Exchange. It employs 15 people.
Currently Active Assets on Macroaxis
Additional Information and Resources on Investing in PDS Stock
When determining whether PDS Biotechnology Corp offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of PDS Biotechnology's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Pds Biotechnology Corp Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Pds Biotechnology Corp Stock:Check out the analysis of PDS Biotechnology Correlation against competitors. You can also try the FinTech Suite module to use AI to screen and filter profitable investment opportunities.